Orthofix Medical Inc. (OFIX)

Orthofix Medical Stock Forecast

Stock Price Forecast

According to 4 professional analysts, the 12-month price target for Orthofix Medical stock ranges from a low of $16 to a high of $24. The average analyst price target of $21.5 forecasts a 93.87% increase in the stock price over the next year.

Price Target: $21.50 (+93.87%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$16	$21.5	$24	$24
Change	+44.27%	+93.87%	+116.41%	+116.41%

Analyst Ratings

The average analyst rating for Orthofix Medical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jan '25	Feb '25	Mar '25	Apr '25	May '25	Jun '25
Strong Buy	3	3	3	3	3	3
Buy	0	0	0	0	0	1
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	4	4	4	4	4	5

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Michael Petusky Barrington Research	Barrington Research	Buy Initiates $16	Buy	Initiates	$16	+44.27%	Jun 23, 2025
David Turkaly JMP Securities	JMP Securities	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	Jun 6, 2025
Caitlin Burrows Canaccord Genuity	Canaccord Genuity	Strong Buy Maintains $24	Strong Buy	Maintains	$24	+116.41%	Feb 26, 2025
Jason Wittes Roth MKM	Roth MKM	Strong Buy Reiterates $22	Strong Buy	Reiterates	$22	+98.38%	Feb 26, 2025
Caitlin Burrows Canaccord Genuity	Canaccord Genuity	Strong Buy Initiates $24	Strong Buy	Initiates	$24	+116.41%	Jan 22, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

831.57M

Increased by 4.01%

from 799.49M

Revenue Next Year

882.09M

Increased by 6.08%

from 831.57M

EPS This Year

0.17

from -3.30

EPS Next Year

0.85

Increased by 403.03%

from 0.17

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	406.56M	464.48M	460.71M	746.64M	799.49M	831.57M	882.09M	950.91M
Revenue Growth	-11.61%	14.25%	-0.81%	62.06%	7.08%	4.01%	6.08%	7.80%
EPS	0.13	-1.95	-0.98	-4.12	-3.30	0.17	0.85	0.80
EPS Growth	-	-	-	-	-	-	403.03%	-6.02%
Forward PE	-	-	-	-	-	65.89	13.10	13.94
No. Analysts	-	-	-	-	-	8	8	5

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	864.7M	941.4M	1.0B
Avg	831.6M	882.1M	950.9M
Low	792.8M	826.4M	883.5M

Revenue Growth

Revenue Growth	2025	2026	2027
High	8.2%	13.2%	14.3%
Avg	4.0%	6.1%	7.8%
Low	-0.8%	-0.6%	0.2%

EPS Forecast

EPS	2025	2026	2027
High	0.65	1.32	0.85
Avg	0.17	0.85	0.80
Low	-0.28	0.39	0.74

EPS Growth

EPS Growth	2025	2026	2027
High	-	686.1%	0.5%
Avg	-	403.0%	-6.0%
Low	-	132.9%	-13.2%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.